NRX Pharmaceuticals (NRXP) Return on Invested Capital (2021 - 2025)
NRX Pharmaceuticals' (NRXP) quarterly Return on Invested Capital came in at 0.13% in Q3 2025, up 3.0% year-on-year from 0.12% in Q3 2024, and up 20.84% on a QoQ basis from 0.16% in Q3 2024.
NRX Pharmaceuticals (NRXP) Return on Invested Capital (2021 - 2025) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 3 years of Return on Invested Capital data on file, last reported at 0.13% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.13% |
| Sep 30, 2024 | -0.16% |
| Sep 30, 2021 | -0.03% |